INS and Insulin resistance: While not currently available for UKB participants, other quantitative measures of insulin resistance in MAP3K15 PTV carriers such as fasting glucose, glucose tolerance tests, and α-hydroxybutyrate levels would further illuminate how MAP3K15 modulates the insulin/glucagon signaling balance and influences hyperglycemia.